Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Crown Bioscience announces its results for the second quarter ending June 30, 2017.
read more
Thursday, November 16, 2017
Crown Bioscience has held an extraordinary general meeting and announced results of stockholder elections for the company’s 2017 Board of Directors.
read more
Crown Bioscience has expanded its oncology services with new models, cell lines and assays at its Center of Excellence for Oncology in San Diego.
read more
Tuesday, December 18, 2018
Crown Bioscience has recently announced the expansion of its existing translational oncology research capacity by opening a new site in Suzhou, Jiangsu, China.
read more
Crown Bioscience, Inc., a leading global drug discovery and development service company, today announces that it has entered into a strategic partnership with Shin Nippon Biomedical Laboratories, Ltd., a Japan-based company engaged in the provision ...
read more
Wednesday, December 16, 2015
Crown Bioscience, a global drug discovery and development services company that has the world’s largest collection of spontaneously diabetic translational models, has established an ultrasound diagnostic method by using its translational model for ...
read more
Thursday, December 03, 2015
Crown Bioscience, a global drug discovery and development services company providing translational platforms to advance oncology and metabolic disease research, has significantly increased the capacity of its United Kingdom facilities.
read more
Thursday, November 08, 2018
Crown Bioscience announced the expansion of its New Iberia, Louisiana research facilities to support novel capabilities including non-GLP clinical chemistry, biomarker services and proprietary early stage preclinical models.
read more
Wednesday, October 14, 2015
Crown Bioscience has entered an exclusive preclinical services alliance utilizing the world’s largest collection of naturally occurring diabetic translational models.
read more
Crown Bioscience has announced the appointment of Amar Thyagarajan, Ph.D., and Sandeep Sinha, Ph.D., to its team.
read more
Crown Bioscience has released another collection of life science products to its e-commerce platform.
read more
Wednesday, October 02, 2024
Crown Bioscience, a contract research organization (CRO) headquartered in San Diego, California in the United States, and a part of JSR Life Sciences and JSR Corporation, recently acquired by Japan Investment Corporation Capital Co., Ltd. , today ...
read more
Crown Bioscience, a global drug discovery and development services company providing translational platforms to advance oncology and metabolic disease research, has expanded its San Diego facility to create CrownBio’s U.S. Center of Excellence for ...
read more
Tuesday, October 20, 2015
Crown Bioscience, a global drug discovery and development services company providing translational platforms to advance oncology and metabolic disease research, has announced the appointment of two respected industry veterans to its business ...
read more
Tuesday, January 09, 2018
CrownSyn is now available as an add-on feature to all two-drug combinatorial studies conducted by Crown Bioscience.
read more